Slide 1: BIOLASE, Inc. Investor Update September 2013
BIOLASE, Inc. Federico Pignatelli, Chairman & CEO Alexander K. Arrow, MD, President & COO NASDAQ: BIOL www.biolase.com Investor Update September 2013 Exhibit 99.1
Slide 2: BIOLASE invented, developed, patented a different tissue-cutting tool
BIOLASE has: • Invented, • Developed, • Patented, and been granted FDA clearances for a fundamentally different kind of tissue-cutting tool PAGE
Slide 3: WaterLase All-Tissue Lasers
• Water molecules within tissue absorb laser energy from the WaterLase and vaporize, resulting in an atraumatic ablation of the tissue. – Very little trauma or bleeding, – No heat or vibration, and – Little or no pain – Significantly reduces cross contamination WaterLase All-Tissue Lasers PAGE • Ext
Slide 4: Patient Testimony
Patient Testimony
Slide 5: How It Works: WaterLase High Speed Cutting
How It Works: WaterLase High Speed Cutting
Slide 6: WaterLase Atraumatic Pediatric Tooth Extraction
WaterLase Atraumatic Pediatric Tooth Extraction The aiming beam does not cut the tissue nor generate heat. The tissue is cut biologically, with little or no pain, when the laser energizes water at the molecular level.
Slide 7: BIOLASE Evolution
BIOLASE Evolution. BIOLASE
Slide 8: BIOLASE Products
Digital Imaging: Best-in-class digital imaging equipment, including cone beam 3-D dental imaging and CAD/CAM digital dental impressions. Non-Dental: The EPIC-V, and coming soon, the EPIC-S Diode soft-tissue dental lasers: The EPIC 10 Soft Tissue laser, which in June 2013 won the MDE gold medal in me
Slide 9: Diversification in 2013
2012 (Actual) 2013 (Projected) Our near term focus is to continue to emphasize our core dental laser business and our growing line of digital imaging systems and CAD/CAM intra-oral scanners. We entered the Veterinary market in Q3 and may enter the ENT market in Q4 2013. Diversification in 2013 Denta
Slide 10: Why Should Dentists Buy a Waterlase iPlus?
Monthly Finance Payment New Monthly Revenue Generated Why Should Dentists Buy a Waterlase iPlus? • WaterLase enables dentists to perform procedures that they would otherwise refer to specialists, for example: • Gingivectomy = $160 - $200 • Perio Treatment = $375 - $1,000 • Hard-tissue Crown Lengthen
Slide 11: Value Proposition of WaterLase
• WaterLase dentists offer their customers more procedures and they have a higher rate of acceptance. Patients are more likely to accept treatment if it does not hurt them. • Case Study: Doctor David Peck (Springfield, MA) – $1M practice in 2010; purchased a WaterLase iPlus in January 2011. – Practi
Slide 12: Who have we been selling to?
Who have we been selling to? PAGE
Slide 13: Diode Soft-Tissue Dental Lasers
• EPIC 10 total diode solution – regulatory clearance late Q3 (EU) & early Q4 (US) 2012. – cleared for 3 unique uses: Soft Tissue Surgery, Whitening, Pain Therapy. Diode Soft-Tissue Dental Lasers • iLase – portable diode laser. – no foot pedal, power cord, or external controls.
Slide 14: In-Licensed Products
• TRIOS intra-oral scanner and cart: – digital impression taking. – handheld scanner, operator's control cart, and software. – North American distribution agreement through Aug 2017. In-Licensed Products • NewTom/Cefla 3D cone beam imaging products: – medical grade imaging technology. – less cost, l
Slide 15: NN rie
NN rie ree | es we | an | Zon id cy, | ‘ow Od doped
Slide 16: PAGE
PAGE
Slide 17: BIOLASE
BIOLASE
Slide 18: BIOLASE lasers are to other cutting tools like a smart phone is to a telephone
BIOLASE lasers are to other cutting tools like a smart phone is to a telephone PAGE
Slide 19: The Dental Drill vs. the WaterLase
The Dental Drill vs. the WaterLase PAGE
Slide 20: * Cutting * Cutting
* Cutting * Cutting * Teeth whitening * Coagulation * Disinfection * Bio-stimulation * Desensitization
Slide 21: Annual Net Revenue and Stock Price
Annual Net Revenue and Stock Price Projected revenue guidance of approximately $68 million, last updated August 7, 2013.
Slide 22: Quarterly Net Revenue and Influencers in Turnaround
Quarterly Net Revenue and Influencers in Turnaround
Slide 23: BIOLASE's Market Opportunity
• 160,000 dentists in US & Canada. • Approximately 1.5 M dentists in 134 countries. – rapid growth in emerging economies e.g. China, India & Indonesia. • Current market penetration. – approx. 5.0% of dental practices in US. – approx. 1.5% worldwide. • Each incremental 1% market penetration equals ov
Slide 24: Dominant Market Position
80% 45% Dominant Market Position WW Hard-tissue Dental Laser Market WW Total Dental Laser Market BIOLASE Market Share
Slide 25: WaterLase Technology Substantially Reduces Risk of Cross Contamination
WaterLase Technology Substantially Reduces the Risk of Cross Contamination and Contagion Burs and Endo Files: WaterLase Tips: • Complex and rugged bur surface difficult to sterilize. • Smooth tip surface does not harbor debris or bacteria like abrasive surface of burs or files. • YSGG laser energy i
Slide 26: Extensive Patent Portfolio
Issued & Active Pending Total • 314 patents issued & pending. • 70% are related to WaterLase technology & medical lasers. Extensive Patent Portfolio U.S. International Total
Slide 27: BIOLASE Facilities & Employees
BIOLASE Corporate Headquarters in Irvine, California • Sales offices in Floss (Germany), Madrid (Spain), Shanghai (China), and Mumbai (India); expansion planned in Dubai (UAE), and Rio de Janero (Brazil). • Floss also has service and manufacturing capabilities. • Training facility at corporate HQ wi
Slide 28: Management and Board of Directors
Management and Board of Directors Management – Salary $1, ownership position 5.5% – Ownership position: 1.5% – Ownership position: 0.7% Board of Directors PAGE • Federico Pignatelli, Chairman • Gregory Lichtwardt • Erin Enright • Frederic Moll, MD • Alexander Arrow, MD • Norman Nemoy , MD • Federico